Measuring Drug Safety ROI Is Difficult, but Feasible RESEARCH TRIANGLE PARK, NC--(Marketwire - June 17, 2010) -  Communicating return on investment (ROI) is a low priority for many drug safety and pharmacovigilance teams, says life sciences...

Drug Safety Outsourcing Requires Careful Scrutiny of Pros and Cons RESEARCH TRIANGLE PARK, NC--(Marketwire - May 25, 2010) -  A new research study shows that the decision to outsource pharmacovigilance activities is connected closely to company size, cultural...

Drug Safety Budgets Must Be Defended, ROI Measured RESEARCH TRIANGLE PARK, NC--(Marketwire - May 19, 2010) -  Drug safety and pharmacovigilance teams play a critical role before, during and after a product launch, but are not finding themselves...